Key result
Transbronchial lung biopsy successfully diagnoses lymphangitic carcinomatosis, offering a less invasive diagnostic option.
Why the study?
Does transbronchial lung biopsy effectively diagnose lymphangitic carcinomatosis?
Case Report (n=6)
Does transbronchial lung biopsy effectively diagnose lymphangitic carcinomatosis?
Transbronchial lung biopsy is a relatively noninvasive technique that can effectively diagnose lymphangitic carcinomatosis of the lung.
Answers are grounded in this paper and cite their sources.
Supports transbronchial biopsy feasibility in suspected lymphangitic carcinomatosis; hypothesis-generating and should not yet change practice.
The clinical diagnosis of lymphangitic carcinomatosis of the lung has generally been confirmed by open lung or transthoracic needle biopsy, precedures with significant morbidity and mortality, particularly in patients with respiratory insufficiency. We present six cases of lymphangitic carcinomatosis diagnosed by transbronchial biopsy. Autopsy confirmation was obtained in 4 patients and ultrastructural confirmation of intralymphatic location of tumor in one. The diffuse bronchial and peribronchial lymphatic involvement demonstrated here suggests that this relatively noninvasive technique should be the procedure of choice in the diagnosis of lymphangitic carcinomatosis of the lung.
No takes yet. Share an insight, caveat, or question.
Aranda et al. (1978) conducted a case report in Lymphangitic carcinomatosis of the lung (n=6). Transbronchial lung biopsy was evaluated on Diagnosis of lymphangitic carcinomatosis. Transbronchial lung biopsy successfully diagnosed lymphangitic carcinomatosis in 6 patients, suggesting it should be the procedure of choice due to its relatively noninvasive nature.
Synapse has enriched 10 related papers. Consider them for comparative context: